Sign Up Now!
To sign up for our newsletter or print publications, enter your contact information below.
First Name
Last Name
Address
Address (Continued)
City
State/Province
ZIP/Postal Code
Country
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegowina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Keeling Islands
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia Hrvatska
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands Malvinas
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Jamaica
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint LUCIA
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia (Slovak Republic)
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zambia
Zimbabwe
Print Edition
E-Newsletters & Communications
I have reviewed and consent to the terms of
TON
's
Privacy Policy
, and
TON
has my permission to retain my information in its database, and to forward pertinent communications to me.
Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe
Home
Issues
2019
December 2019 - Vol 12 No 6
October 2019 - Vol 12 No 5
August 2019 - Vol 12 No 4
June 2019 - Vol 12 No 3
April 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 5
September 2018 - Vol 11 No 4
July 2018 - Vol 11 No 3
May 2018 - Vol 11 No 2
March 2018 - Vol 11 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
TON Interview with the Innovators Series
Audiocasts
Quick Quiz
CE
About
About TON
Contact Us
Editorial Board
Advertise
Resources
For Authors
Author Guidelines
Phoebe Starr
Authored Items
Long-Term Data Confirm Survival Benefit for Pembrolizumab in Advanced NSCLC
Phoebe Starr
Web Exclusives
in
Lung Cancer
Adding CDK4/6 Inhibitor to Endocrine Therapy Improves Survival in Advanced Breast Cancer: New Standard of Care
Phoebe Starr
Web Exclusives
in
ESMO
,
Breast Cancer
Reduced-Intensity Chemotherapy for Frail Elderly Patients with Advanced Gastroesophageal Cancer
Phoebe Starr
TON - October 2019, Vol 12, No 5
in
Geriatric Cancer
Fixed-Duration Venetoclax plus Obinutuzumab New Standard of Care for Front-Line Treatment of Patients with CLL and Comorbidities
Phoebe Starr
TON - October 2019, Vol 12, No 5
in
Leukemia
MONALEESA-7 Sets New Standard of Care for Premenopausal Women with Advanced Breast Cancer
Phoebe Starr
TON - August 2019, Vol 12, No 4
in
Breast Cancer
Studies Show ACA Reduces Disparities and Increases Access to Earlier Diagnosis and Treatment
Phoebe Starr
TON - August 2019, Vol 12, No 4
in
ASCO
Osimertinib plus Savolitinib Promising for Non–Small-Cell Lung Cancer with MET-Driven Resistance
Phoebe Starr
TON - June 2019, Vol 12, No 3
in
Lung Cancer
High Tumor Mutation Burden Predictive Biomarker for Survival in Metastatic Non–Small-Cell Lung Cancer
Phoebe Starr
TON - June 2019, Vol 12, No 3
in
Lung Cancer
Gilteritinib a New Standard of Care for Relapsed or Refractory AML with FLT3 Mutation
Phoebe Starr
TON - June 2019, Vol 12, No 3
in
Leukemia
Infigratinib a Novel, Potent Selective TKI Targeting FGFR Fusions in Different Tumor Types
Phoebe Starr
TON - June 2019, Vol 12, No 3
in
Emerging Therapies
Umbralisib Shows Encouraging Results in Relapsed or Refractory Marginal-Zone Lymphoma
Phoebe Starr
TON - June 2019, Vol 12, No 3
in
Lymphoma
Explosive Development of BCMA CAR T-Cell Therapies for Multiple Myeloma
Phoebe Starr
TON - April 2019, Vol 12, No 2
in
Immunotherapy
5 mg Tamoxifen as Effective as 20 mg Daily in Early Localized Breast Cancer
Phoebe Starr
TON - February 2019, Vol 12, No 1
in
Breast Cancer
Weight-Loss Intervention in Women with Breast Cancer Works Only with Adherence
Phoebe Starr
TON - February 2019, Vol 12, No 1
in
Breast Cancer
Checkpoint Inhibitor a New Approach to Jump-Start a Waning Response to CAR T-Cell Therapy
Phoebe Starr
TON - February 2019, Vol 12, No 1
in
Immunotherapy
Paradigm Shift: Radiation a New Standard in Prostate Cancer with Low Metastatic Burden
Phoebe Starr
TON - February 2019, Vol 12, No 1
in
Prostate Cancer
Researchers Identify First Mutation to Explain Resistance to Venetoclax
Phoebe Starr
TON - February 2019, Vol 12, No 1
in
Leukemia
First-Line Olaparib a New Standard in Women with Newly Diagnosed, BRCA-Positive Advanced Ovarian Cancer?
Phoebe Starr
TON - February 2019, Vol 12, No 1
in
Ovarian Cancer
Nivolumab plus Ipilimumab Combo Controls Brain Metastases in Patients with Melanoma
Phoebe Starr
TON - November 2018, Vol 11, No 5
in
Melanoma
TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition
Phoebe Starr
TON - November 2018, Vol 11, No 5
in
Emerging Therapies
With Access to Care, Black Men in the United States Have Same Prostate Cancer Outcomes as White Men
Phoebe Starr
TON - September 2018, Vol 11, No 4
in
Prostate Cancer
Acquired HER2 Mutations in Metastatic Breast Cancer Confer Resistance to ER-Directed Therapy
Phoebe Starr
TON - July 2018, Vol 11, No 3
in
Breast Cancer
Chlamydia Trachomatis Infection Doubles the Risk for Ovarian Cancer
Phoebe Starr
TON - May 2018, Vol 11, No 2
in
Ovarian Cancer
Adjuvant Chemotherapy in Upper-Tract Urothelial Cancer Shows Impressive Gains in the POUT Trial
Phoebe Starr
TON - May 2018, Vol 11, No 2
in
Genitourinary Cancers
Emerging Safety Data with Checkpoint Inhibitors
Phoebe Starr
TON - November 2017, Vol 10, No 6
in
Conference Correspondent
Psychological Distress in Patients with Cancer Warrants Attention
Phoebe Starr
TON - November 2017, Vol 10, No 6
in
Conference Correspondent
Patients’ Chemotherapy-Related Side-Effect Concerns Have Evolved, But Hair Loss Remains Significant
Phoebe Starr
TON - November 2017, Vol 10, No 6
in
Conference Correspondent
Increased Cancer Risk in Postmenopausal Women with Central Obesity
Phoebe Starr
TON - November 2017, Vol 10, No 6
in
Conference Correspondent
Patients’ Fears of Radiation Side Effects Largely Unfounded
Phoebe Starr
TON - November 2017, Vol 10, No 6
in
Conference Correspondent
Novel Drug “Home Run” for TRK Mutation–Positive Tumors
Phoebe Starr
TON - November 2017, Vol 10, No 6
in
Emerging Therapies
Healthy Lifestyle Improves Survival in Patients with Colon Cancer
Phoebe Starr
TON - September 2017, Vol 10, No 5
in
Colorectal Cancer
,
Conference Correspondent
8-Week Internet-Based Psychological Intervention Reduces Stress in Patients Newly Diagnosed with Cancer
Phoebe Starr
TON - September 2017, Vol 10, No 5
in
Conference Correspondent
More Support for Regular Use of Low-Dose Aspirin
Phoebe Starr
TON - September 2017, Vol 10, No 5
in
Conference Correspondent
Cardiotoxicity with Targeted Therapies Is Rare, but Requires Attention
Phoebe Starr
TON - September 2017, Vol 10, No 5
in
Conference Correspondent
Survivorship Care Evolves with Fine-Tuning
Phoebe Starr
TON - July 2017, Vol 10, No 4
in
Survivorship
Reasons for Emergency Department Visits Related to Immune Checkpoint Inhibitor Treatment
Phoebe Starr
TON - July 2017, Vol 10, No 4
in
Side-Effects Management
,
Side-Effects Management
Hormonal Therapy Associated with Anxiety in Men with Localized Prostate Cancer
Phoebe Starr
TON - May 2017, Vol 10, No 3
in
Genitourinary Cancers
New NCCN Distress Guidelines and Tools Encourage Patients to Speak Up
Phoebe Starr
TON - May 2017, Vol 10, No 3
in
Conference Correspondent
,
NCCN
Discontinuing Immunotherapy Because of Adverse Effects May Not Compromise Efficacy
Phoebe Starr
TON - May 2017, Vol 10, No 3
in
Side-Effects Management
,
Side-Effects Management
Toxicities of Immunotherapy Require Awareness, Education
Phoebe Starr
TON - May 2017, Vol 10, No 3
in
Side-Effects Management
,
Side-Effects Management
Autologous Breast Reconstruction Has Better Outcomes Than Implants in Patients Receiving Radiotherapy
Phoebe Starr
TON - March 2017, Vol 10, No 2
in
Breast Cancer
Specific Menopausal Symptoms Associated with Nonadherence to Hormonal Therapy in Women at Risk for Breast Cancer
Phoebe Starr
TON - March 2017, Vol 10, No 2
in
Breast Cancer
R-CHOP Prevails Over Dose-Adjusted EPOCH-R as Standard of Care for Diffuse Large B-Cell Lymphoma
Phoebe Starr
Web Exclusives
in
Conference Correspondent
,
In the News
Strategies to Reduce the Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Phoebe Starr
Web Exclusives
in
Conference Correspondent
,
In the News
Increased Attention to Cardiovascular Events in DLBCL Warranted
Phoebe Starr
TON - January 2017, Vol 10, No 1
in
Conference Correspondent
Use Caution When Placing Catheters in Children with Cancer
Phoebe Starr
TON - January 2017, Vol 10, No 1
in
Conference Correspondent
Call to Action: Address Patients’ Sexual Health
Phoebe Starr
TON - November 2016, Vol 9, No 6
in
Supportive Care
Older Drugs in “New Clothes” Achieve Superior Outcomes
Phoebe Starr
TON - November 2016, Vol 9, No 6
in
Hematologic Cancers
Aggressive End-of-Life Care Continues to Be Offered to Younger Patients with Cancer
Phoebe Starr
TON - September 2016, Vol 9, No 5
in
Best Practices
,
Palliative Care
Aspirin Reduces Risk for Prostate Cancer Death
Phoebe Starr
TON March 2016 Vol 9 No 2
in
Genitourinary Cancers
Docetaxel Does Not Compromise Long-Term QOL in Men with Metastatic Hormone-Sensitive Prostate Cancer
Phoebe Starr
TON March 2016 Vol 9 No 2
in
Genitourinary Cancers
Active Holistic Surveillance Incorporates Diet, Supplements, Exercise for Low-Risk and Low-Intermediate–Risk Prostate Cancer
Phoebe Starr
TON March 2016 Vol 9 No 2
in
Genitourinary Cancers
Chemotherapy, Radiation Safe During Pregnancy in Second or Third Trimester
Phoebe Starr
TON November 2015 Vol 8 No 6
in
Supportive Care
ABCs of Immunotherapy
Phoebe Starr
TON September 2015 Vol 8 No 5
in
Online First
The State of Antibody-Drug Conjugates in 2015
Phoebe Starr
TON September 2015 Vol 8 No 5
in
Drug Therapies
Being Single Raises Risks of Death for Patients with Cancer
Phoebe Starr
TON July 2015 Vol 8 No 4
in
Supportive Care
No Role for Adjuvant Sorafenib or Sunitinib in Locally Advanced Kidney Cancer
Phoebe Starr
TON May 2015 Vol 8 No 3
in
Genitourinary Cancers
AR-V7 Predicts Chemotherapy Sensitivity in Metastatic Prostate Cancer
Phoebe Starr
TON May 2015 Vol 8 No 3
in
Genitourinary Cancers
Novel Agent Effective for the Management of Cancer-Related Cachexia
Phoebe Starr
TON - January 2015 Vol 8 No 1
in
Supportive Care
Role of Radiation and Imaging in DCIS Explained
Phoebe Starr
TON - January/February 2014 Vol 7 No 1
in
Breast Cancer
Pazopanib: First Positive Maintenance Trial
Phoebe Starr
TON - December 2013 Vol 6 No 11
in
Gynecologic Cancers
Two-Thirds of Women Experience Musculoskeletal Toxicity on Aromatase Inhibitors and 22.9% Discontinue Therapy
Phoebe Starr
TON - March 2013, Vol 6, No 2
in
Breast Cancer
Last modified: December 21, 2012
Home
Issues
2019
December 2019 - Vol 12 No 6
October 2019 - Vol 12 No 5
August 2019 - Vol 12 No 4
June 2019 - Vol 12 No 3
April 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
November 2018 - Vol 11 No 5
September 2018 - Vol 11 No 4
July 2018 - Vol 11 No 3
May 2018 - Vol 11 No 2
March 2018 - Vol 11 No 1
Issue Archive
Special Issues
Supplements
Guide to New FDA Approvals
2019 Fourth Annual Guide
2018 Third Annual Guide
2017 Second Annual Guide
2016 First Annual Guide
Categories
Conference Correspondent
Web Exclusives
All Web Exclusives
Drug Updates
FDA Approvals, News & Updates
In the News
Online First
Press Releases
Media Library
Videos
TON Interview with the Innovators Series
Audiocasts
Quick Quiz
CE
About
About TON
Contact Us
Editorial Board
Advertise
Resources
For Authors
Author Guidelines